“…More in general, NK cells can be activated by various stimuli such as contact with dendritic cells (DC), MHC-I-negative cells, binding of IgG immunocomplexes, direct engagement of NKR by stress-induced tumor-associated molecules or pathogen-derived products, and several cytokines such as IL-1, IL-2, IL-12, IL-15, IL-18, IL-21, and type I IFNs (8 -25). Upon cytokine stimulation, NK cells become lymphokine-activated killer (LAK) cells that proliferate, produce cytokines, and upregulate effector molecules such as adhesion molecules, NKp44, perforin, granzymes, Fas ligand (FasL), and TRAIL (8,9,12,(25)(26)(27)(28)(29). Thanks to this new pattern of protein expression, LAK cells enhance their ability to adhere to and recognize target cells, leading to a broader killing activity against tumor cells that essentially takes place as (30): 1) perforin/granzyme-dependent necrosis of target cells, involving cell adhesion, NKR triggering, and granule release (31,32); and 2) apoptosis of target cells, which involves cell adhesion and is mediated by surface TNF ligand family members a) FasL, b) TNF-␣, and c) TRAIL, each of which interacts with specific receptors on the target cell surface (26 -29).…”